Comparison of the utility of multiplex tests for non-small cell lung cancer with necrosis-rich tumors.
Not Applicable
Recruiting
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000051503
- Lead Sponsor
- Matsusaka Municipal Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(i) Cases where it is deemed difficult to submit ODxTT and AmoyDx with FFPE specimens, and Compact Panel Dx with FFPE or cytology specimens due to sample volume, or where the aforementioned multi-gene tests make it difficult to submit other tests considered necessary in routine clinical practice. (ii) Cases in which the tumor cell percentage is less than 30% even if macrodissection is performed. (iii) Other cases deemed unsuitable by the physician in charge.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success rate of analysis using ODxTT and AmoyDx with FFPE specimens and Compact Panel Dx with FFPE or cytology specimens.
- Secondary Outcome Measures
Name Time Method Comparison of success rates between ODxTT and Compact Panel Dx; comparison of success rates between ODxTT and AmoyDx; driver gene detection rates by analysis using ODxTT and AmoyDx in FFPE specimens and Compact Panel Dx using FFPE or cytology specimens.